Novartis India Limited (BOM:500672)
922.15
+22.75 (2.53%)
At close: May 21, 2025
Novartis India Revenue
In the fiscal year ending March 31, 2025, Novartis India had annual revenue of 3.56B INR with 6.33% growth. Novartis India had revenue of 838.80M in the quarter ending March 31, 2025, with 3.34% growth.
Revenue
3.56B
Revenue Growth
+6.33%
P/S Ratio
6.39
Revenue / Employee
57.46M
Employees
62
Market Cap
22.77B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 3.56B | 212.00M | 6.33% |
Mar 31, 2024 | 3.35B | -436.70M | -11.53% |
Mar 31, 2023 | 3.79B | -211.30M | -5.28% |
Mar 31, 2022 | 4.00B | 185.20M | 4.86% |
Mar 31, 2021 | 3.81B | -569.00M | -12.98% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,646.93B |
HDFC Bank | 2,728.47B |
Tata Consultancy Services | 2,553.24B |
Bharti Airtel | 1,729.85B |
ICICI Bank | 2,006.54B |
State Bank of India | 3,429.39B |
Infosys | 1,647.16B |
Bajaj Finance | 369.88B |
Novartis India News
- 8 months ago - Novartis India stock surges 9% as Alkem Labs eyes ₹2,000 crore acquisition - Business Upturn